Abstract
OBJECTIVES: The peroxisome proliferator-activated receptor-α (PPAR-α) has attracted considerable attention for its anti-inflammatory properties; however, Toll-like receptor (TLR) pathways have an essential proinflammatory role in acute pancreatitis (AP). This study aimed to evaluate the attenuation of inflammation by PPAR-α and to investigate the interaction between PPAR-α and TLR pathways in AP. METHODS: Acute pancreatitis was induced in rats by administration of cerulein. The PPAR-α agonist WY14643 and/or antagonist MK886 was administered. The severity of AP was determined by measuring serum amylase, lipase, Ca, pathological changes, myeloperoxidase activity, serum levels of interleukin (IL)-6, and intercellular adhesion molecule-1 (ICAM-1). The TLR2 and TLR4 messenger RNA (mRNA) and proteins were determined by real-time reverse transcriptase polymerase chain reaction and Western blotting, respectively. The mRNA expressions of target molecules of TLR pathways, including IL-6, IL-10, ICAM-1, and tumor necrosis factor α were also measured. RESULTS: Treatment with WY14643 significantly decreased amylase, lipase, myeloperoxidase activity, pathological scores, IL-6, and ICAM-1 levels. The TLR2 and TLR4 mRNA and proteins were markedly decreased after treatment with WY14643, along with IL-6, ICAM-1, and tumor necrosis factor α mRNA levels. However, these effects were completely reversed by the coadministration of MK886. CONCLUSIONS: Activation of PPAR-α played a protective role in AP, partially mediated by modulation of TLR pathways. Copyright © 2012 by Lippincott Williams & Wilkins.
Author supplied keywords
Cite
CITATION STYLE
Ding, J. L., Zhou, Z. G., Zhou, X. Y., Zhou, B., Wang, L., Wang, R., … Li, Y. (2013). Attenuation of acute pancreatitis by peroxisome proliferator-activated receptor-α in rats: The effect on toll-like receptor signaling pathways. Pancreas, 42(1), 114–122. https://doi.org/10.1097/MPA.0b013e3182550cc4
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.